Grant: CIHR Fellowship
Direct Payment
$150,000.00
Identification of genetic risk factors in severe pediatric tuberculosis
FY 2012-13
Summary
Most humans, particularly those living in developing countries, are exposed to virulent, air-borne human-tropic mycobacteria at some point in their lives. These include M. tuberculosis, which causes clinical disease among a minority of exposed individuals. Despite widespread use of antibiotics, 8 million new cases of tuberculosis (TB) are reported annually worldwide, resulting in almost 2 million deaths. Distinct forms of clinical disease in children vs. adults have been observed in M. tuberculosis endemic areas. Pediatric and adult TB differ markedly in epidemiological features, clinical appearance, and pathogenesis. Severe, disseminated and often-fatal TB in children results from hematogenous spread of M. tuberculosis during primary infection of genetically vulnerable individuals. The inter-individual variability in response to M. tuberculosis is thought to result in part from polymorphism in host immune response genes, however the causal mutations have not yet been identified. Therefore TB, particularly severe life-threatening infections among children, is not only an infectious disease but also a genetic disorder. We propose a multi-disciplinary project, integrating basic and clinical immunology and genetics, to discover TB susceptibility genes in children and develop rational therapeutics.
Department
Program
CIHR Fellowship
Recipient
Location
New York, United States of America
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
269496
Name
Markle Janet
Region
New York
Country
United States of America
Orgtype
Research Institution
Instname2
Genetics
Theme2
Biomedical
Prcname2
Fellowships - Post-PhD
Projecttitle
Identification of genetic risk factors in severe pediatric tuberculosis
Programtype2
Fellowship Programs
Orgnameinp2
Direct Payment
Cihramount2
$150,000
Cihrequipment2
$0
Programname2
CIHR Fellowship
Keyworddelim
Human Genetics; Immune Response; Infectious Diseases; Mycobacterial Pathogenesis
Abstract
Most humans, particularly those living in developing countries, are exposed to virulent, air-borne human-tropic mycobacteria at some point in their lives. These include M. tuberculosis, which causes clinical disease among a minority of exposed individuals. Despite widespread use of antibiotics, 8 million new cases of tuberculosis (TB) are reported annually worldwide, resulting in almost 2 million deaths. Distinct forms of clinical disease in children vs. adults have been observed in M. tuberculosis endemic areas. Pediatric and adult TB differ markedly in epidemiological features, clinical appearance, and pathogenesis. Severe, disseminated and often-fatal TB in children results from hematogenous spread of M. tuberculosis during primary infection of genetically vulnerable individuals. The inter-individual variability in response to M. tuberculosis is thought to result in part from polymorphism in host immune response genes, however the causal mutations have not yet been identified. Therefore TB, particularly severe life-threatening infections among children, is not only an infectious disease but also a genetic disorder. We propose a multi-disciplinary project, integrating basic and clinical immunology and genetics, to discover TB susceptibility genes in children and develop rational therapeutics.
Competitiondate
201210
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Markle, Janet
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $150,000~ $0~